Literature DB >> 2564414

Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.

W W Wong1, J M Cahill, M D Rosen, C A Kennedy, E T Bonaccio, M J Morris, J G Wilson, L B Klickstein, D T Fearon.   

Abstract

Structural and quantitative polymorphisms have been described in human CR1. In the former, the S allotype is larger than the F allotype by 40-50 kD, the size of a long homologous repeat (LHR). In the latter, homozygotes for a 7.4-kb Hind III fragment express fourfold more CR1 per erythrocyte than do homozygotes for the allelic 6.9-kb restriction fragment. The basis for these genomic polymorphisms has been determined by restriction mapping the entire S allele and part of the F allele. The S allele is 158 kb and contains 5 LHRs of 20-30 kb, designated -A, -B/A, -B, -C, and -D, respectively, 5' to 3'. Extensive homology was found among the LHRs in their restriction maps, exon organization, and the coding and noncoding sequences. The presence of LHR-B/A in the S allele but not in the F allele accounts for the longer transcripts and polypeptide associated with the former allotype. At least 42 exons are present in the S allele, with distinct exons for the leader sequence, the transmembrane and cytoplasmic regions and most of the SCRs comprising the extracellular portion of CR1. Consistent with the mapping of the ligand binding site to the first two SCRs in each LHR, the second SCRs in LHR-A, -B/A, -B, and -C are encoded by two exons, reflecting a specialized function for this unit. The allelic 7.4/6.9-kb Hind III fragments extend from the 3' region of LHR-C to LHR-D. The 6.9-kb restriction fragment is the result of a new Hind III site generated by a single base change in the intron between the exons encoding the second SCR of LHR-D. A second cluster of genomic clones has been identified by hybridization to CR1 probes. Although they contain regions of hybridization to the cDNA and genomic probes derived from CR1, these cannot be overlapped with the structural gene owing to their distinct restriction maps. Three genomic polymorphisms previously identified by CR1 cDNA probes map to this region. These additional clones may represent part of a duplicated allele located nearby within the CR1 locus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564414      PMCID: PMC2189269          DOI: 10.1084/jem.169.3.847

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.

Authors:  V M Holers; D D Chaplin; J F Leykam; B A Gruner; V Kumar; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

2.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.

Authors:  S H Yoon; D T Fearon
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

4.  Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.

Authors:  F Moldenhauer; J David; A H Fielder; P J Lachmann; M J Walport
Journal:  Arthritis Rheum       Date:  1987-09

5.  The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.

Authors:  S Van Dyne; V M Holers; D M Lublin; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

6.  Selective synthesis of mRNA and proteins by human peripheral blood neutrophils.

Authors:  R M Jack; D T Fearon
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

7.  Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

Authors:  M C Carroll; E M Alicot; P J Katzman; L B Klickstein; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

8.  Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans.

Authors:  J Rey-Campos; P Rubinstein; S Rodriguez de Cordoba
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

9.  A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.

Authors:  J Rey-Campos; P Rubinstein; S Rodriguez de Cordoba
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.

Authors:  D M Lublin; R S Lemons; M M Le Beau; V M Holers; M L Tykocinski; M E Medof; J P Atkinson
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  30 in total

Review 1.  C4b-binding protein, a regulatory protein of complement.

Authors:  S R Barnum
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Soluble form of complement C3b/C4b receptor (CR1) results from a proteolytic cleavage in the C-terminal region of CR1 transmembrane domain.

Authors:  I Hamer; J P Paccaud; D Belin; C Maeder; J L Carpentier
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

3.  Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts.

Authors:  E A Putnam; E S Park; C M Aalfs; R C Hennekam; D M Milewicz
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis.

Authors:  Swapan K Nath; John B Harley; Young Ho Lee
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 5.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Bacterial expression and membrane targeting of the rat complement regulator Crry: a new model anticomplement therapeutic.

Authors:  Deborah A Fraser; Claire L Harris; Richard A G Smith; B Paul Morgan
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

7.  Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement.

Authors:  F Pardo-Manuel; J Rey-Campos; A Hillarp; B Dahlbäck; S Rodriguez de Cordoba
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.

Authors:  P Cornillet; P Gredy; J L Pennaforte; O Meyer; M D Kazatchkine; J H Cohen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

9.  Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.

Authors:  D Guc; P Gulati; C Lemercier; D Lappin; G D Birnie; K Whaley
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

10.  A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.

Authors:  Daniel J Birmingham; Fawzi Irshaid; Katherine F Gavit; Haikady N Nagaraja; C Yung Yu; Brad H Rovin; Lee A Hebert
Journal:  Mol Immunol       Date:  2007-04-30       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.